AMETEK (NYSE:AME) Share Price Crosses Below Two Hundred Day Moving Average on Analyst Downgrade

AMETEK, Inc. (NYSE:AME)’s share price passed below its 200-day moving average during trading on Thursday after Mizuho lowered their price target on the stock from $285.00 to $275.00. The stock has a 200-day moving average of $234.54 and traded as low as $222.23. Mizuho currently has an outperform rating on the stock. AMETEK shares last traded at $222.5910, with a volume of 2,537,120 shares changing hands.

Several other equities analysts also recently weighed in on AME. Royal Bank Of Canada lifted their target price on shares of AMETEK from $260.00 to $291.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Rothschild & Co Redburn upped their price target on shares of AMETEK from $265.00 to $275.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Citigroup upped their price target on shares of AMETEK from $261.00 to $263.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. Robert W. Baird raised their price objective on shares of AMETEK from $275.00 to $280.00 and gave the stock a “neutral” rating in a report on Monday, October 5th. Finally, Truist Financial lifted their price objective on shares of AMETEK from $303.00 to $316.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, AMETEK presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.06.

Insider Buying and Selling

In other AMETEK news, insider David Hermance sold 6,608 shares of AMETEK stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the completion of the transaction, the insider owned 42,509 shares of the company’s stock, valued at $10,797,286. The trade was a 13.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.54% of the stock is currently owned by corporate insiders.

Trending Headlines about AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: AMETEK reported record third-quarter sales, with earnings beating estimates. Organic sales growth, a record backlog and margin expansion supported higher 2026 earnings and free-cash-flow guidance. Zacks Q3 earnings article
• Positive Sentiment: RBC raised its price target to $308 from $291 and maintained an Outperform rating. RBC price-target update
• Positive Sentiment: Citigroup lifted its target to $270 from $263, while keeping a Neutral rating. Citigroup rating
• Neutral Sentiment: Mizuho lowered its target to $275 from $285 but retained an Outperform rating, reflecting a more cautious target alongside continued optimism. Mizuho price-target update
• Negative Sentiment: AME fell sharply after the results, despite the earnings beat and raised outlook. The reaction suggests investors may have been expecting more or were taking profits; the cited coverage does not confirm a specific catalyst. Yahoo Finance analysis of AMETEK’s post-results decline

Hedge Funds Weigh In On AMETEK

A number of large investors have recently modified their holdings of AME. Frazier Financial Advisors LLC bought a new position in AMETEK in the 2nd quarter valued at $25,000. Fiduciary Financial Advisors purchased a new position in shares of AMETEK during the 2nd quarter valued at $27,000. Elevation Wealth Partners LLC increased its holdings in shares of AMETEK by 239.5% in the second quarter. Elevation Wealth Partners LLC now owns 129 shares of the technology company’s stock worth $31,000 after purchasing an additional 91 shares during the period. GK Wealth Management LLC bought a new position in shares of AMETEK in the third quarter worth $36,000. Finally, NFSG Corp purchased a new stake in shares of AMETEK in the third quarter worth $48,000. 87.43% of the stock is currently owned by institutional investors.

AMETEK Stock Down 6.1%

The company has a market cap of $51.04 billion, a PE ratio of 31.40, a P/E/G ratio of 2.11 and a beta of 0.96. The stock has a 50-day moving average of $243.19 and a 200-day moving average of $234.54. The company has a quick ratio of 0.76, a current ratio of 1.43 and a debt-to-equity ratio of 0.52.

AMETEK (NYSE:AME) last posted its earnings results on Tuesday, November 3rd. The technology company reported $2.21 EPS for the quarter, topping the consensus estimate of $2.11 by $0.10. The business had revenue of $2.22 billion during the quarter, compared to analysts’ expectations of $2.12 billion. AMETEK had a return on equity of 17.12% and a net margin of 19.91%. The firm’s revenue was up 17.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.89 earnings per share. Sell-side analysts predict that AMETEK, Inc. will post 8.59 earnings per share for the current fiscal year.

About AMETEK

AMETEK, Inc is a global manufacturer of industrial technology solutions. The company develops and produces advanced analytical, monitoring, testing, and measurement instruments, as well as engineered electromechanical products used in industrial, aerospace, defense, energy, medical, and other specialized markets.

AMETEK operates through two primary business groups: Electronic Instruments and Electromechanical. Its products include process and power monitoring systems, analytical instruments, automation and control technologies, aerospace and defense equipment, precision motion-control systems, motors, thermal-management solutions, engineered materials, and specialty metal products.

The company traces its roots to 1930 and has expanded through the development and acquisition of specialized technology businesses.